396 related articles for article (PubMed ID: 26525194)
1. Efficient genomic correction methods in human iPS cells using CRISPR-Cas9 system.
Li HL; Gee P; Ishida K; Hotta A
Methods; 2016 May; 101():27-35. PubMed ID: 26525194
[TBL] [Abstract][Full Text] [Related]
2. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
3. Generation and validation of PAX7 reporter lines from human iPS cells using CRISPR/Cas9 technology.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Stem Cell Res; 2016 Mar; 16(2):220-8. PubMed ID: 26826926
[TBL] [Abstract][Full Text] [Related]
4. Efficient, footprint-free human iPSC genome editing by consolidation of Cas9/CRISPR and piggyBac technologies.
Wang G; Yang L; Grishin D; Rios X; Ye LY; Hu Y; Li K; Zhang D; Church GM; Pu WT
Nat Protoc; 2017 Jan; 12(1):88-103. PubMed ID: 27929521
[TBL] [Abstract][Full Text] [Related]
5. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.
Sürün D; Schneider A; Mircetic J; Neumann K; Lansing F; Paszkowski-Rogacz M; Hänchen V; Lee-Kirsch MA; Buchholz F
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32384610
[TBL] [Abstract][Full Text] [Related]
6. Generation of Isogenic Human iPS Cell Line Precisely Corrected by Genome Editing Using the CRISPR/Cas9 System.
Grobarczyk B; Franco B; Hanon K; Malgrange B
Stem Cell Rev Rep; 2015 Oct; 11(5):774-87. PubMed ID: 26059412
[TBL] [Abstract][Full Text] [Related]
7. Highly efficient biallelic genome editing of human ES/iPS cells using a CRISPR/Cas9 or TALEN system.
Takayama K; Igai K; Hagihara Y; Hashimoto R; Hanawa M; Sakuma T; Tachibana M; Sakurai F; Yamamoto T; Mizuguchi H
Nucleic Acids Res; 2017 May; 45(9):5198-5207. PubMed ID: 28334759
[TBL] [Abstract][Full Text] [Related]
8. Generation and Characterization of a MYF5 Reporter Human iPS Cell Line Using CRISPR/Cas9 Mediated Homologous Recombination.
Wu J; Hunt SD; Xue H; Liu Y; Darabi R
Sci Rep; 2016 Jan; 6():18759. PubMed ID: 26729410
[TBL] [Abstract][Full Text] [Related]
9. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
10. CRISPR Base Editing in Induced Pluripotent Stem Cells.
Chang YJ; Xu CL; Cui X; Bassuk AG; Mahajan VB; Tsai YT; Tsang SH
Methods Mol Biol; 2019; 2045():337-346. PubMed ID: 31250381
[TBL] [Abstract][Full Text] [Related]
11. From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing.
Hotta A; Yamanaka S
Annu Rev Genet; 2015; 49():47-70. PubMed ID: 26407033
[TBL] [Abstract][Full Text] [Related]
12. FACS-Assisted CRISPR-Cas9 Genome Editing Facilitates Parkinson's Disease Modeling.
Arias-Fuenzalida J; Jarazo J; Qing X; Walter J; Gomez-Giro G; Nickels SL; Zaehres H; Schöler HR; Schwamborn JC
Stem Cell Reports; 2017 Nov; 9(5):1423-1431. PubMed ID: 28988985
[TBL] [Abstract][Full Text] [Related]
13. Genome Engineering for Stem Cell Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.
Giacalone JC; Sharma TP; Burnight ER; Fingert JF; Mullins RF; Stone EM; Tucker BA
Curr Protoc Stem Cell Biol; 2018 Feb; 44():5B.7.1-5B.7.22. PubMed ID: 29512106
[TBL] [Abstract][Full Text] [Related]
15. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
Horii T; Hatada I
Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
[TBL] [Abstract][Full Text] [Related]
16. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
17. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
Li M; Hunt JFVS; Bhattacharyya A; Zhao X
Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
[TBL] [Abstract][Full Text] [Related]
18. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
[TBL] [Abstract][Full Text] [Related]
19. Genome engineering tools for building cellular models of disease.
Lin J; Musunuru K
FEBS J; 2016 Sep; 283(17):3222-31. PubMed ID: 27218233
[TBL] [Abstract][Full Text] [Related]
20. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
